Hot Keywords
Latest Volumes
-
Recent advances in immunotherapy for pancreatic cancer
Review|Published on: 6 Nov 2020 -
A review on exosome-based cancer therapy
Review|Published on: 6 Nov 2020
Original Articles See more
-
Protection of small-cell lung cancer circulating tumor cells by cellular fragmentation
Published on: 17 Sep 2020 -
-
Lobe-specific modulation of B16MET melanoma lung metastases by nephrilin peptide
Published on: 30 Jul 2020 -
-
Combinatorial treatment of curcumin or silibinin with doxorubicin sensitises high-risk neuroblastoma
Published on: 13 Mar 2020
-
Lobe-specific modulation of B16MET melanoma lung metastases by nephrilin peptide
Published on: 30 Jul 2020
-
Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators
Published on: 13 Mar 2020
Review Articles See more
-
The systemic hallmarks of cancer
Published on: 28 Aug 2020 -
Targeting epithelial-mesenchymal transition - an ongoing wild goose chase
Published on: 28 Aug 2020 -
Mouse tumor susceptibility genes identify drug combinations for multiple myeloma
Published on: 26 Jul 2020
-
Magnetic nanotechnologies for early cancer diagnostics with liquid biopsies: a review
Published on: 10 Jul 2020 -
Deubiquitination in prostate cancer progression: role of USP22
Published on: 18 Jun 2020 -
Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancer
Published on: 23 May 2020
Others See more
Nivolumab-induced severe bullous pemphigoid in a patient with renal cancer: a case report and literature review
-
Could zinc dipicolinate be used to “smuggle” zinc into prostate cancer cells?
Commentary|Published on: 19 Jul 2020 -
Cyclophosphamide, fluorouracil and low-dose interleukin-2 and salvage combination chemotherapy in advanced cutaneous squamous cell carcinoma
Case Report|Published on: 24 Jun 2020 -
Evaluating different routes of extracellular vesicle administration for cranial therapies
Technical Note|Published on: 18 Jun 2020 -
Letting go of the physical exam: embracing telehealth solutions to oncology
Perspective|Published on: 28 Apr 2020
Most Cited Papers In Last Two Years See more
Photodynamic therapy in cancer treatment - an update review
-
A pilot study for distinguishing basal cell carcinoma from normal human skin tissues using visible resonance Raman spectroscopy
Original Article|Published on: 23 Jan 2019 -
Targeting autophagy with small molecules for cancer therapy
Review|Published on: 19 Apr 2019
-
ESR1 alterations and metastasis in estrogen receptor positive breast cancer
Review|Published on: 4 May 2019 -
Circulating microRNAs and liquid biopsy: murine xenograft models for technical validation of clinical protocols
Review|Published on: 26 Jun 2019 -
Update on targeted therapy and immune therapy for gastric cancer, 2018
Review|Published on: 28 Jun 2018
Ongoing Special Issues See more
-
Topic: Tumor-Associated Macrophages and Tumour Progression and Treatment
Submission Deadline: 31 Dec 2021
Published articles: 0
-
Topic: Treatment Strategies for Metastatic Colorectal Cancer
Submission Deadline: 31 Oct 2021
Published articles: 0
-
Topic: Treatment Strategies of Pulmonary Metastasis
Submission Deadline: 30 Jun 2021
Published articles: 0
-
Topic: Advanced Research on the Treatment of Ovarian Cancer
Submission Deadline: 31 May 2021
Published articles: 0
-
Topic: Long Noncoding RNAs in Cancer Metastasis
Submission Deadline: 31 May 2021
Published articles: 0
-
-
Special Issue Ebooks See more
About The Journal
-
ISSN
2454-2857 (Online) 2394-4722 (Print)
Publisher
OAE Publishing Inc.
Article Processing Charge
$299
-
Editor-in-Chief
Lucio MielePublishing Model
Gold Open Access
Copyright
Copyright is retained by authors
-
Publishing Frequency
Continuously published
Contact Us
editorialoffice@jcmtjournal.com
Journal Data Analysis
Total publications: 329
Total article views: 2,107,374
Total article downloads: 158,979
Membership
-
COPE
Journal of Cancer Metastasis and Treatment is a member of the Committee on Publication Ethics (COPE) and fully adhere to its Code of Conduct and to its Best Practice Guidelines.
-
STM
Journal of Cancer Metastasis and Treatment is a member of and subscribes to the principles of STM. Authors of jcmt can reuse a certain quantity of article contents from the chargeable publications of other STM members for free in their submissions to jcmt.
-
ORCID
Journal of Cancer Metastasis and Treatment is a member of ORCID and our MESAs system has been connected with ORCID. After submissions to jcmt are published, they will be automatically synchronized to the authors' ORCID accounts if the authors have connected their MESAs accounts with ORCID accounts. jcmt's reviewers can choose to synchronize their review records to their ORCID accounts when filling in review reports.
-
Crossref
Journal of Cancer Metastasis and Treatment is a member of Crossref, which makes research outputs easy to find, cite, link, assess, and reuse.
-
iThenticate
All submissions to Journal of Cancer Metastasis and Treatment are checked for plagiarism by iThenticate.
-
Check for updates
All published articles in Journal of Cancer Metastasis and Treatment are enriched with a record of the current article status.
